Benzinga | Nov 5, 2021 09:32AM EDT

Cardiff Oncology Q3 EPS $(0.17) Up From $(0.19) YoY, Sales $86.00K Down From $136.00K YoY

Cardiff Oncology (NASDAQ:CRDF) reported quarterly losses of $(0.17) per share. This is a 10.53 percent increase over losses of $(0.19) per share from the same period last year. The company reported $86.00 thousand in sales this quarter. This is a 36.76 percent decrease over sales of $136.00 thousand the same period last year.